Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan
Introduction Although the prognosis of Langerhans cell histiocytosis (LCH) is excellent, the high recurrence rate and permanent consequences, such as central diabetes insipidus and LCH-associated neurodegenerative diseases, remain to be resolved. Based on previous reports that patients with high-ris...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2024-06-01
|
| Reeks: | BMJ Open |
| Online toegang: | https://bmjopen.bmj.com/content/14/6/e084159.full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
